Pneumagen Leverages its Novel Glycan Approach to Target Coronavirus (COVID-19) Infections

Novel Carbohydrate Binding Modules block entry into airway cells for a range of viruses causing respiratory tract infections ST ANDREWS, Scotland, March 17, 2020 /PRNewswire/ — Pneumagen Ltd , focused on treating infectious disease and oncology by targeting the human glycome, today announced it has initiated a new programme […]

Click here to view original web page at